182 related articles for article (PubMed ID: 16029321)
1. Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight.
Hussein MR
Br J Dermatol; 2005 Jul; 153(1):18-21. PubMed ID: 16029321
[TBL] [Abstract][Full Text] [Related]
2. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
Carlsson B; Sadeghi A; Bengtsson M; Wagenius G; Tötterman TH
J Immunother; 2008 Sep; 31(7):633-43. PubMed ID: 18600181
[TBL] [Abstract][Full Text] [Related]
3. T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.
Strohal R; Paucz L; Pehamberger H; Stingl G
Cancer Res; 1994 Sep; 54(17):4734-9. PubMed ID: 8062272
[TBL] [Abstract][Full Text] [Related]
4. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
[TBL] [Abstract][Full Text] [Related]
5. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.
Ferradini L; Mackensen A; Genevée C; Bosq J; Duvillard P; Avril MF; Hercend T
J Clin Invest; 1993 Mar; 91(3):1183-90. PubMed ID: 8450047
[TBL] [Abstract][Full Text] [Related]
6. [Cytotoxic T-cell immune response against melanoma antigens].
Ayyoub M
Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S34-6. PubMed ID: 9922891
[No Abstract] [Full Text] [Related]
7. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
Hussein MR; Elsers DA; Fadel SA; Omar AE
J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
[TBL] [Abstract][Full Text] [Related]
8. T-cell distribution and adhesion receptor expression in metastatic melanoma.
Weishaupt C; Munoz KN; Buzney E; Kupper TS; Fuhlbrigge RC
Clin Cancer Res; 2007 May; 13(9):2549-56. PubMed ID: 17473183
[TBL] [Abstract][Full Text] [Related]
9. Current concepts of tumor-infiltrating lymphocytes in human malignancies.
Chiou SH; Sheu BC; Chang WC; Huang SC; Hong-Nerng H
J Reprod Immunol; 2005 Oct; 67(1-2):35-50. PubMed ID: 16111767
[TBL] [Abstract][Full Text] [Related]
10. MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.
Godet Y; Moreau-Aubry A; Guilloux Y; Vignard V; Khammari A; Dreno B; Jotereau F; Labarriere N
J Exp Med; 2008 Oct; 205(11):2673-82. PubMed ID: 18936238
[TBL] [Abstract][Full Text] [Related]
11. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
12. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
[TBL] [Abstract][Full Text] [Related]
13. Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients.
Molenkamp BG; Sluijter BJ; van Leeuwen PA; Santegoets SJ; Meijer S; Wijnands PG; Haanen JB; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2008 Jul; 14(14):4532-42. PubMed ID: 18628468
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases.
Mourmouras V; Fimiani M; Rubegni P; Epistolato MC; Malagnino V; Cardone C; Cosci E; Nisi MC; Miracco C
Br J Dermatol; 2007 Sep; 157(3):531-9. PubMed ID: 17596146
[TBL] [Abstract][Full Text] [Related]
15. Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.
Griffioen M; Kessler JH; Borghi M; van Soest RA; van der Minne CE; Nouta J; van der Burg SH; Medema JP; Schrier PI; Falkenburg JH; Osanto S; Melief CJ
Clin Cancer Res; 2006 May; 12(10):3130-6. PubMed ID: 16707612
[TBL] [Abstract][Full Text] [Related]
16. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
Bodey B; Bodey B; Siegel SE; Luck JV; Kaiser HE
Anticancer Res; 1996; 16(6B):3439-46. PubMed ID: 9042204
[TBL] [Abstract][Full Text] [Related]
18. Association between natural killer cells and regression in melanocytic lesions.
McKay K; Moore PC; Smoller BR; Hiatt KM
Hum Pathol; 2011 Dec; 42(12):1960-4. PubMed ID: 21676435
[TBL] [Abstract][Full Text] [Related]
19. Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer.
Lu P; Zhu XQ; Xu ZL; Zhou Q; Zhang J; Wu F
Surgery; 2009 Mar; 145(3):286-93. PubMed ID: 19231581
[TBL] [Abstract][Full Text] [Related]
20. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
